| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -38,718 | -30,577 |
| Depreciation and amortization | 6,524 | 4,444 |
| Loss on disposal of assets | -5 | - |
| Net (accretion) amortization of (discounts) premiums on investments | 207 | 165 |
| Stock-based compensation | 6,598 | 4,580 |
| Non-cash interest expense related to sale of future royalties | 2,277 | 1,670 |
| Non-cash revenue related to sale of future royalties | 4,521 | 4,521 |
| Accounts receivable | 36,955 | -1,480 |
| Unbilled receivable from government contracts | 37,021 | 30,573 |
| Prepaid expenses and other assets | -1,951 | -1,534 |
| Prepaid clinical services, long-term | 0 | - |
| Accounts payable | 46,218 | 3,648 |
| Deferred revenue-Government Contract | -572 | -23 |
| Other accrued liabilities | 31,472 | 22,959 |
| Net cash used in operating activities | -22,949 | -25,544 |
| Purchases of property and equipment | 144 | 27 |
| Proceeds from sale of property and equipment | 5 | - |
| Purchases of investments | 19,218 | 9,808 |
| Proceeds from maturities of investments | 34,000 | 30,300 |
| Net cash provided by (used in) investing activities | 14,643 | 20,465 |
| Net proceeds from issuance of common stock-June2024Offering | 0 | 0 |
| Net proceeds from issuance of common stock-Atthemarket Facility | 53 | 53 |
| Net proceeds from issuance of common stock-RACapital Healthcare Fund2024 | 0 | 0 |
| Proceeds from issuance of common stock upon exercise of stock options | 3 | 3 |
| Shares acquired to settle employee tax withholding liabilities | 178 | 174 |
| Proceeds from issuance of common stock under the employee stock purchase plan | 0 | 0 |
| Proceeds from issuance of treasury stock under the employee stock purchase plan | 79 | 79 |
| Net cash (used in) provided by financing activities | -43 | -39 |
| Net decrease in cash and cash equivalents | -8,349 | -5,118 |
| Cash and cash equivalents at beginning of period | 25,229 | - |
| Cash and cash equivalents at end of period | 16,880 | - |
Vaxart, Inc. (VXRT)
Vaxart, Inc. (VXRT)